课题基金 / 基金详情

Mobile Adaptation and Testing of a Uniquely Targeted HIV Intervention for Young Transgender Women

Mobile Adaptation and Testing of a Uniquely Targeted HIV Intervention for Young Transgender Women
针对年轻跨性别女性的独特针对性艾滋病毒干预措施的移动适应和测试
批准号:
9765545
负责人:
Lisa Mary Kuhns
金额:
$30.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-21 至 2020-09-20

项目摘要

项目成果

Lisa Mary Kuhns的其他基金

相似基金

相关文献

中文摘要
翻译
这项拟议研究的目标是适应“生活技能”-一个有效的和独特的目标群体- 为16-29岁有艾滋病毒风险的年轻变性妇女(YTW)提供基于艾滋病毒预防的干预措施 传输或采集-到移动的平台;并且一旦适应,就进行全面的随机化 对照试验(RCT),以确定其在降低艾滋病毒风险行为方面的疗效。在美国,YTW是一把钥匙 艾滋病毒感染的高风险人群,美国城市YTW中的艾滋病毒流行率估计为 19- 22%。有证据表明,社会经济边缘化和相关的心理社会共同- 发病率驱动高水平的艾滋病毒相关风险YTW,表明需要全面的艾滋病毒预防 针对其独特情况和脆弱性的方案。到目前为止,还没有证据表明 YTW的艾滋病毒预防干预措施(EBI)列在CDC的EBI汇编中;干预措施包括 需要广泛扩展到实践环境。我们将通过以下方式解决这一差距 研究目标:1)使生活技能适应移动的网络平台,包括1a)修订和更新 生活技能干预,包括扩大的艾滋病毒生物医学预防和治疗模式(例如,PrEP 和艾滋病毒治疗作为预防); 1b)调整干预内容,使之适合移动的部署, 通过定性焦点小组,以用户为中心,在每个入组研究中心建立更大的研究团队和YTW 设计会议和可用性测试。2)对经过调整的移动的干预措施进行试点测试,以提高可行性 40名16-29岁的YTW有HIV感染或传播风险(10名参与者/研究中心) 并准备全面实施。3)测试移动的生活技能干预在以下方面的有效性: 与延迟干预对照组的主要结局比较:无安全套性交次数 行为(肛门和阴道; 4个月召回)没有保护的PrEP/ART;和次要结局: 艾滋病毒/性传播感染(泌尿生殖道/肛门衣原体和淋病、梅毒)。此外,我们将:3a) 通过干预措施的概念性调解人,研究干预组之间艾滋病毒风险的调解: 跨性别适应/融合,集体自尊/赋权,信息,动机, 行为技能3b)与对照组相比,评估移动的生活技能干预的有效性 艾滋病毒预防和护理连续性成果的条件,包括PrEP/艾滋病毒护理联系, 启动和保留,并通过HIV状态(实验室确认)评估效果改变。
英文摘要
The goals of this proposed study are to adapt “LifeSkills”- an efficacious and uniquely targeted group- based HIV prevention intervention for young transgender women (YTW) ages 16-29, at risk for HIV transmission or acquisition- to a mobile platform; and once adapted, to conduct a full-scale randomized controlled trial (RCT) to determine its efficacy in decreasing HIV risk behavior. In the U.S., YTW are a key population at high risk of HIV infection, with HIV prevalence estimates in U.S. among urban YTW ranging from 19-22%. Evidence suggests that socioeconomic marginalization, and related psychosocial co- morbidities drive high levels of HIV-related risk YTW, indicating a need for comprehensive HIV prevention programs targeted to their unique circumstances and vulnerabilities. To date there are no evidence-based HIV prevention interventions (EBIs) for YTW listed in the CDC compendium of EBIs; interventions are needed that are widely scalable to the practice environment. We will address this gap via the following study aims: 1) adapting LifeSkills to a mobile web-based platform, including 1a) revising and updating the LifeSkills intervention to include expanded biomedical HIV prevention and treatment modalities (e.g., PrEP and HIV Treatment as Prevention); 1b) adapting the intervention content for mobile deployment with the larger investigative team and YTW at each enrollment site via qualitative focus groups, user-centered design sessions, and usability testing. 2) Pilot testing the adapted mobile intervention to enhance feasibility and acceptability with 40 YTW ages 16-29 at-risk of HIV acquisition or transmission (10 participants/site) and prepare for full implementation. 3) Testing the efficacy of the mobile LifeSkills intervention in comparison to a delayed intervention control group on the primary outcome: number of condomless sex acts (anal and vaginal; 4-month recall) without protection of PrEP/ART; and secondary outcome: acquisition of HIV/STIs (urogenital/anal chlamydia and gonorrhea, syphilis). Furthermore, we will: 3a) examine mediation in HIV risk between intervention groups by the conceptual mediators of the intervention: transgender adaptation/integration, collective self-esteem/empowerment, information, motivation, and behavioral skills. 3b) assess the efficacy of the mobile LifeSkills intervention in comparison to the control condition on outcomes across the HIV prevention and care continuum, including PrEP/HIV care linkage, initiation, and retention, with assessment of effect modification by HIV status (lab-confirmed).
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.2196/21839
发表时间: 2021-03-31
期刊: Journal of medical Internet research
影响因子: 7.4
作者: [Kuhns LM, Hereth J, Garofalo R, Hidalgo M, Johnson AK, Schnall R, Reisner SL, Belzer M, Mimiaga MJ]
通讯作者: Mimiaga MJ
海外基金